Related references
Note: Only part of the references are listed.Non-Motor Symptoms of Parkinson's Disease: The Neurobiology of Early Psychiatric and Cognitive Dysfunction
Ayan Hussein et al.
NEUROSCIENTIST (2023)
The Molecular Mechanism of Scutellaria baicalensis Georgi Stems and Leaves Flavonoids in Promoting Neurogenesis and Improving Memory Impairment by the PI3K-AKT-CREB Signaling Pathway in Rats
Qian-Qian Liu et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2022)
Temporal processing in the striatum: Interplay between midbrain dopamine neurons and striatal cholinergic interneurons
Anne-Caroline Martel et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2021)
Pharmacological Influencing of The Cholinergic Anti-inflammatory Pathway in Infectious Diseases and Inflammatory Pathologies
Miroslav Pohanka
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2021)
Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation
Elizabeth M. Kline et al.
MOVEMENT DISORDERS (2021)
Neuroimaging of Anxiety in Parkinson's Disease: A Systematic Review
Guillaume Carey et al.
MOVEMENT DISORDERS (2021)
Proteomic Complexity in Parkinson's Disease: A Redox Signaling Perspective of the Pathophysiology and Progression
Marcos Martinez-Banaclocha
NEUROSCIENCE (2021)
Neuropathological and Biomarker Findings in Parkinson's Disease and Alzheimer's Disease: From Protein Aggregates to Synaptic Dysfunction
Yaroslau Compta et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Parkinson's Disease: Potential Actions of Lithium by Targeting the WNT/beta-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway
Alexandre Vallee et al.
CELLS (2021)
Two Players in the Field: Hierarchical Model of Interaction between the Dopamine and Acetylcholine Signaling Systems in the Striatum
Jaromir Myslivecek
BIOMEDICINES (2021)
Whole-Brain Mapping of Direct Inputs to Dopamine D1 and D2 Receptor-Expressing Medium Spiny Neurons in the Posterior Dorsomedial Striatum
Jiayi Lu et al.
ENEURO (2021)
Balance alterations and reduction of pedunculopontine cholinergic neurons in early stages of parkinsonism in middle-aged rats
Thassya F. O. dos Santos et al.
EXPERIMENTAL GERONTOLOGY (2021)
Perivascular Spaces in the Basal Ganglia and Long-term Motor Prognosis in Newly Diagnosed Parkinson Disease
Seok Jong Chung et al.
NEUROLOGY (2021)
Complete Evaluation of Dementia: PET and MRI Correlation and Diagnosis for the Neuroradiologist
J. D. Oldan et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2021)
Impact of motor subtype on non-motor symptoms and fall-related features in patients with early Parkinson's disease
Kyum-Yil Kwon et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2021)
Cholinergic modulation of the immune system-A novel therapeutic target for myocardial inflammation
Jing Lu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Whole-brain mapping of monosynaptic inputs to midbrain cholinergic neurons
Icnelia Huerta-Ocampo et al.
SCIENTIFIC REPORTS (2021)
Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity
Namrita Halder et al.
FRONTIERS IN IMMUNOLOGY (2021)
Mechanisms of Neurodegeneration in Various Forms of Parkinsonism-Similarities and Differences
Dariusz Koziorowski et al.
CELLS (2021)
GSK-3 and Tau: A Key Duet in Alzheimer's Disease
Carmen Laura Sayas et al.
CELLS (2021)
Relationships and Interactions between Ionotropic Glutamate Receptors and Nicotinic Receptors in the CNS
Trevor W. Stone
NEUROSCIENCE (2021)
Studying the functional connectivity of the primary motor cortex with the binarized cross recurrence plot: The influence of Parkinson's disease
Clara Rodriguez-Sabate et al.
PLOS ONE (2021)
Structural and functional neuroimaging changes associated with cognitive impairment and dementia in Parkinson's disease
Conor Owens-Walton et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2021)
Cortical Thickness from MRI to Predict Conversion from Mild Cognitive Impairment to Dementia in Parkinson Disease: A Machine Learning-based Model
Na-Young Shin et al.
RADIOLOGY (2021)
Dopaminergic-cholinergic imbalance in movement disorders: a role for the novel striatal dopamine D2- muscarinic acetylcholine M1 receptor heteromer
Rene A. J. Crans et al.
NEURAL REGENERATION RESEARCH (2021)
GABAergic changes in the thalamocortical circuit in Parkinson's disease
Annelies J. M. van Nuland et al.
HUMAN BRAIN MAPPING (2020)
Targeting the cholinergic system in Parkinson's disease
Changliang Liu
ACTA PHARMACOLOGICA SINICA (2020)
Cornel iridoid glycoside improves cognitive impairment induced by chronic cerebral hypoperfusion via activating PI3K/Akt/GSK-3β/CREB pathway in rats
Ming-Yang Wang et al.
BEHAVIOURAL BRAIN RESEARCH (2020)
Phosphorylation Signaling in APP Processing in Alzheimer's Disease
Tao Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Traumatic brain injury preceding clinically diagnosed α-synucleinopathies: A case-control study
Shemonti Hasan et al.
NEUROLOGY (2020)
DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats
Puneet K. Sharma et al.
NEUROTHERAPEUTICS (2020)
Strategies for the Treatment of Parkinson's Disease: Beyond Dopamine
Alexandre Iarkov et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Dangerous Liaisons: Tau Interaction with Muscarinic Receptors
Adrianna Wysocka et al.
CURRENT ALZHEIMER RESEARCH (2020)
Minireview: Divergent roles of α7 nicotinic acetylcholine receptors expressed on antigen-presenting cells and CD4+ T cells in the regulation of T cell differentiation
Masato Mashimo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Roles of nAChR and Wnt signaling in intestinal stem cell function and inflammation
Toshio Takahashi
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Cholinergic midbrain afferents modulate striatal circuits and shape encoding of action strategies
Daniel Dautan et al.
NATURE COMMUNICATIONS (2020)
Impairments in face discrimination and emotion recognition are related to aging and cognitive dysfunctions in Parkinson's disease with dementia
Mary Wen-Reng Ho et al.
SCIENTIFIC REPORTS (2020)
Cotinine Enhances Fear Extinction and Astrocyte Survival by Mechanisms Involving the Nicotinic Acetylcholine Receptors Signaling
Patricia Oliveros-Matus et al.
FRONTIERS IN PHARMACOLOGY (2020)
Biological links between traumatic brain injury and Parkinson's disease
Vedad Delic et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
The role of microglia in the development of neurodegeneration
Aigul R. Saitgareeva et al.
NEUROLOGICAL SCIENCES (2020)
Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors
Benjamin Mappin-Kasirer et al.
NEUROLOGY (2020)
Tobacco smoking and the reduced risk of Parkinson disease: A puzzle of 60 years
Yuan Cheng et al.
NEUROLOGY (2020)
Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling
Roger L. Papke et al.
NEUROPHARMACOLOGY (2020)
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
Uddalak Bharadwaj et al.
PHARMACOLOGICAL REVIEWS (2020)
Neurobiological findings underlying depressive behavior in Parkinson's disease: A review
Ingrid Prata Mendonca et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes
Hector Albert-Gasco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Anatomical Characterization of the Human Structural Connectivity between the Pedunculopontine Nucleus and Globus Pallidus via Multi-Shell Multi-Tissue Tractography
Salvatore Bertino et al.
MEDICINA-LITHUANIA (2020)
Interaction of Alpha-Synuclein With Lipids: Mitochondrial Cardiolipin as a Critical Player in the Pathogenesis of Parkinson's Disease
Valentina Gilmozzi et al.
FRONTIERS IN NEUROSCIENCE (2020)
Cotinine and 6-Hydroxy-L-Nicotine Reverses Memory Deficits and Reduces Oxidative Stress in Aβ25-35-Induced Rat Model of Alzheimer's Disease
Razvan Stefan Boiangiu et al.
ANTIOXIDANTS (2020)
Association of transferrin G258A and transferrin receptor A82G polymorphisms with the risk of Parkinson disease in certain area
Yan Wang et al.
MEDICINE (2020)
Best early-onset Parkinson dementia predictor using ensemble learning among Parkinson's symptoms, rapid eye movement sleep disorder, and neuropsychological profile
Haewon Byeon
WORLD JOURNAL OF PSYCHIATRY (2020)
Cotinine ameliorates memory and learning impairment in senescent mice
Saeed Sadigh-Eteghad et al.
BRAIN RESEARCH BULLETIN (2020)
Cholinergic neurotransmission in the basolateral amygdala during cued fear extinction
Devin M. Kellis et al.
NEUROBIOLOGY OF STRESS (2020)
Smoking Cessation, Weight Change, and Risk of Parkinson's Disease: Analysis of National Cohort Data
Ryul Kim et al.
JOURNAL OF CLINICAL NEUROLOGY (2020)
Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson's disease patients
Maria Chondrogiorgi et al.
BRAIN IMAGING AND BEHAVIOR (2019)
Cholinergic modulation of striatal microcircuits
Nilupaer Abudukeyoumu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2019)
Cholinergic control of striatal neurons to modulate L-dopa-induced dyskinesias
Tanuja Bordia et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2019)
(E)-Nicotinaldehyde O-Cinnamyloxime, a Nicotine Analog, Attenuates Neuronal Cells Death Against Rotenone-Induced Neurotoxicity
Juan Camilo Jurado-Coronel et al.
MOLECULAR NEUROBIOLOGY (2019)
New insights into the complex role of mitochondria in Parkinson's disease
Anne Gruenewald et al.
PROGRESS IN NEUROBIOLOGY (2019)
α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis
Surabhi Mehra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2019)
Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions
Lauren Walker et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Could high lithium levels in tobacco contribute to reduced risk of Parkinson's disease in smokers?
Thomas Guttuso et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Modifiable risk factors for cognitive impairment in Parkinson's disease: A systematic review and meta-analysis of prospective cohort studies
Yu Guo et al.
MOVEMENT DISORDERS (2019)
Nicotine protects against manganese and iron-induced toxicity in SH-SY5Y cells: Implication for Parkinson's disease
Bruk Getachew et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
The Functional Role of Striata Cholinergic Interneurons in Reinforcement Learning From Computational Perspective
Taegyo Kim et al.
FRONTIERS IN NEURAL CIRCUITS (2019)
Medications, Deep Brain Stimulation, and Other Factors Influencing Impulse Control Disorders in Parkinson's Disease
Robert S. Eisinger et al.
FRONTIERS IN NEUROLOGY (2019)
Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment
Seok Jong Chung et al.
HUMAN BRAIN MAPPING (2019)
Dopaminergic modulation of striatal function and Parkinson's disease
Shenyu Zhai et al.
JOURNAL OF NEURAL TRANSMISSION (2019)
Olfactory anosognosia is a predictor of cognitive decline and dementia conversion in Parkinson's disease
Han Soo Yoo et al.
JOURNAL OF NEUROLOGY (2019)
Predicting Progression to Parkinson's Disease Dementia Using Multivariate Normative Comparisons
J. A. Agelink van Rentergem et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2019)
Disentangling the diverse roles of dopamine D2 receptors in striatal function and behavior
Eduardo F. Gallo
NEUROCHEMISTRY INTERNATIONAL (2019)
Freezing of gait and dementia in parkinsonism: A retrospective case-control study
Giovanni Palermo et al.
BRAIN AND BEHAVIOR (2019)
Nicotine Bitartrate Reduces Falls and Freezing of Gait in Parkinson Disease: A Reanalysis
Abraham Lieberman et al.
FRONTIERS IN NEUROLOGY (2019)
Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study
Giovanni Palermo et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium
Thomas Guttuso et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Changing views of the pathophysiology of Parkinsonism
Thomas Wichmann
MOVEMENT DISORDERS (2019)
Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugs
Bryan L. Roth
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease
Samira Ztaou et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
Dopamine Deficiency Reduces Striatal Cholinergic Interneuron Function in Models of Parkinson's Disease
Jonathan W. McKinley et al.
NEURON (2019)
Effects of Muscarinic Acetylcholine m1 and m4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat
Nicole E. Chambers et al.
NEUROSCIENCE (2019)
Putaminal Dopamine Turnover in de novo Parkinson's Disease Predicts Later Neuropsychiatric Fluctuations but Not Other Major Health Outcomes
Matthias Loehle et al.
JOURNAL OF PARKINSONS DISEASE (2019)
Understanding G Protein Selectivity of Muscarinic Acetylcholine Receptors Using Computational Methods
Luis Jaimes Santiago et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity
Thomas Guttuso
MEDICAL HYPOTHESES (2019)
Neuroinflammation disorders exacerbated by environmental stressors
JamesP. O'Callaghan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Medium spiny neurons of the anterior dorsomedial striatum mediate reversal learning in a cell-type-dependent manner
Xingyue Wang et al.
BRAIN STRUCTURE & FUNCTION (2019)
Inhibition of Nigrostriatal Dopamine Release by Striatal GABAA and GABAB Receptors
Emanuel F. Lopes et al.
JOURNAL OF NEUROSCIENCE (2019)
Parkinson's Disease
Stephen G. Reich et al.
MEDICAL CLINICS OF NORTH AMERICA (2019)
Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques
Tom H. Johnston et al.
MOVEMENT DISORDERS (2019)
Molecular Insights Into Memory-Enhancing Metabolites of Nicotine in Brain: A Systematic Review
Alireza Majdi et al.
FRONTIERS IN NEUROSCIENCE (2019)
Striatal Cholinergic Interneurons: How to Elucidate Their Function in Health and Disease
Nicolas Mallet et al.
FRONTIERS IN PHARMACOLOGY (2019)
Differential Nicotinic Modulation of Glutamatergic and GABAergic VTA Microcircuits
Yijin Yan et al.
ENEURO (2019)
Exploring causality of the association between smoking and Parkinson's disease
Valentina Gallo et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2019)
Striatal cholinergic interneurons and Parkinson's disease
Asami Tanimura et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2018)
Intracellular GPCRs Play Key Roles in Synaptic Plasticity
Yuh-Jiin I. Jong et al.
ACS CHEMICAL NEUROSCIENCE (2018)
The genetics of Parkinson disease
Hao Deng et al.
AGEING RESEARCH REVIEWS (2018)
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
Harald Hampel et al.
BRAIN (2018)
Can neuroimaging predict dementia in Parkinson's disease?
Juliette H. Lanskey et al.
BRAIN (2018)
Visual hallucinations in dementia and Parkinson's disease: A qualitative exploration of patient and caregiver experiences
Sarah Renouf et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2018)
Modification of α-synuclein by lipid peroxidation products derived from polyunsaturated fatty acids promotes toxic oligomerization: its relevance to Parkinson disease
Masayo Shamoto-Nagai et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2018)
Non-motor Parkinson disease: new concepts and personalised management
Nataliya Titova et al.
MEDICAL JOURNAL OF AUSTRALIA (2018)
Intranasal Cotinine Plus Krill Oil Facilitates Fear Extinction, Decreases Depressive-Like Behavior, and Increases Hippocampal Calcineurin A Levels in Mice (vol 55, pg 7949, 2018)
Nathalie Alvarez-Ricartes et al.
MOLECULAR NEUROBIOLOGY (2018)
A new outlook on cholinergic interneurons in Parkinson's disease and L-DOPA-induced dyskinesia
Melissa M. Conti et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease
Brenna Cholerton et al.
PARKINSONISM & RELATED DISORDERS (2018)
Dementia with Lewy Bodies and Parkinson Disease Dementia: It is the Same Disease!
Joseph H. Friedman
PARKINSONISM & RELATED DISORDERS (2018)
α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies
Iryna Prots et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
A Review of the Pedunculopontine Nucleus in Parkinson's Disease
Isobel T. French et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
Xian-Si Zeng et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson's Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage
Jing Zou et al.
AGING AND DISEASE (2018)
Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson's Disease
Paula A. Q. Videira et al.
FRONTIERS IN NEUROSCIENCE (2018)
Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration
Maria J. Perez et al.
FRONTIERS IN NEUROSCIENCE (2018)
Diversity of Interneurons in the Dorsal Striatum Revealed by Single-Cell RNA Sequencing and PatchSeq
Ana B. Munoz-Manchado et al.
CELL REPORTS (2018)
Wnt/β-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson's Disease
Bianca Marchetti
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Cotinine Plus Krill Oil Decreased Depressive Behavior, and Increased Astrocytes Survival in the Hippocampus of Mice Subjected to Restraint Stress
Cristhian Mendoza et al.
FRONTIERS IN NEUROSCIENCE (2018)
Targeted Activation of Cholinergic Interneurons Accounts for the Modulation of Dopamine by Striatal Nicotinic Receptors
Katherine R. Brimblecombe et al.
ENEURO (2018)
Nonmotor Symptoms of Parkinson's Disease as Predictors of Dementia
Mohammed Wasif Hussain et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2018)
Parkinson's disease: experimental models and reality
Peizhou Jiang et al.
ACTA NEUROPATHOLOGICA (2018)
Cholinergic regulation of fear learning and extinction
Marlene A. Wilson et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease
Ahsan Habib et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
Relationship Between Obesity, Alzheimer's Disease, and Parkinson's Disease: an Astrocentric View
Cynthia Alexandra Martin-Jimenez et al.
MOLECULAR NEUROBIOLOGY (2017)
Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson's Disease
Junjun Zhao et al.
MOLECULAR NEUROBIOLOGY (2017)
Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson's disease genes
Laura Scott et al.
EXPERIMENTAL NEUROLOGY (2017)
Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons
Ravi Rajmohan et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Physiological functions of the cholinergic system in immune cells
Takeshi Fujii et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2017)
Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson's disease
James A. Duce et al.
MOLECULAR NEURODEGENERATION (2017)
L-Dopa Responsiveness Is Associated With Distinctive Connectivity Patterns in Advanced Parkinson's Disease
Harith Akram et al.
MOVEMENT DISORDERS (2017)
Striato-cortical Connections in Parkinson's and Alzheimer's Diseases: Relation to Cognition
Lubomira Anderkova et al.
MOVEMENT DISORDERS (2017)
Mild Cognitive Impairment as a Risk Factor for Parkinson's Disease Dementia
Jeroen Hoogland et al.
MOVEMENT DISORDERS (2017)
Cognitive decline in Parkinson disease
Dag Aarsland et al.
NATURE REVIEWS NEUROLOGY (2017)
α6β2 subunit containing nicotinic acetylcholine receptors exert opposing actions on rapid dopamine signaling in the nucleus accumbens of rats with high-versus low-response to novelty
Cody A. Siciliano et al.
NEUROPHARMACOLOGY (2017)
THE ROLE OF THE INTRINSIC CHOLINERGIC SYSTEM OF THE STRIATUM: WHAT HAVE WE LEARNED FROM TAN RECORDINGS IN BEHAVING ANIMALS?
Paul Apicella
NEUROSCIENCE (2017)
Nicotine facilitates nicotinic acetylcholine receptor targeting to mitochondria but makes them less susceptible to selective ligands
Kateryna Uspenska et al.
NEUROSCIENCE LETTERS (2017)
Cotinine improves visual recognition memory and decreases cortical Tau phosphorylation in the Tg6799 mice
J. Alex Grizzell et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Structural Brain Connectome and Cognitive Impairment in Parkinson Disease
Sebastiano Galantucci et al.
RADIOLOGY (2017)
Neurotransmission systems in Parkinson's disease
Hossein Sanjari Moghaddam et al.
REVIEWS IN THE NEUROSCIENCES (2017)
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease
Lena F. Burbulla et al.
SCIENCE (2017)
Dopamine and Acetylcholine, a Circuit Point of View in Parkinson's Disease
Giorgio Rizzi et al.
FRONTIERS IN NEURAL CIRCUITS (2017)
Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson's Disease
Ying Wang et al.
NEUROSCIENCE BULLETIN (2017)
Dementia Predictors in Parkinson Disease: A Validation Study
Julius B. M. Anang et al.
JOURNAL OF PARKINSONS DISEASE (2017)
Cholinergic Modulation of Type 2 immune Responses
Goele Bosmans et al.
FRONTIERS IN IMMUNOLOGY (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Sensitivity analysis of discharge patterns of subthalamic nucleus in the model of basal ganglia in Parkinson disease
Jyotsna Singh et al.
JOURNAL OF INTEGRATIVE NEUROSCIENCE (2017)
Dementia-Predicting Cognitive Risk Score and Its Correlation with Cortical Thickness in Parkinson Disease
Byoung Seok Ye et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2017)
M-4 Muscarinic Receptors and Locomotor Activity Regulation
J. Myslivecek et al.
PHYSIOLOGICAL RESEARCH (2017)
Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model
Yuan Liu et al.
BIOCHEMICAL PHARMACOLOGY (2017)
The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?
Sandra Franco-Iborra et al.
NEUROSCIENTIST (2016)
Altered Mitochondrial DNA Methylation Pattern in Alzheimer Disease-Related Pathology and in Parkinson Disease
Marta Blanch et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Physiology of freezing of gait
Anke H. Snijders et al.
ANNALS OF NEUROLOGY (2016)
The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease
Audrey Maillet et al.
BRAIN (2016)
Connectivity Changes in Parkinson's Disease
Antonio Cerasa et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)
Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson's Disease
Juan Camilo Jurado-Coronel et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
The Role of alpha 7 Nicotinic Acetylcholine Receptors and alpha 7-Specific Antibodies in Neuroinflammation Related to Alzheimer Disease
Maryna Skok et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Neuroinflammation: A Therapeutic Target of Cotinine for the Treatment of Psychiatric Disorders?
Valentina Echeverria et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases
Michael H. Irwin et al.
DRUG DEVELOPMENT RESEARCH (2016)
Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management
Niyatee Samudra et al.
DRUGS & AGING (2016)
Mitochondrial control of cell bioenergetics in Parkinson's disease
Raquel Requejo-Aguilar et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Microglial AGE-albumin is critical for neuronal death in Parkinson's disease: a possible implication for theranostics
Seong Soo An et al.
International Journal of Nanomedicine (2016)
Mitochondrial dysfunction in Parkinson's disease
Anindita Bose et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Nicotinic receptor subtypes differentially modulate glutamate release in the dorsal medial striatum
William M. Howe et al.
NEUROCHEMISTRY INTERNATIONAL (2016)
Cholinergic Signaling Controls Conditioned Fear Behaviors and Enhances Plasticity of Cortical-Amygdala Circuits
Li Jiang et al.
NEURON (2016)
Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline
Elizabeth C. Ballinger et al.
NEURON (2016)
THE INOSITOL TRISPHOSPHATE/CALCIUM SIGNALING PATHWAY IN HEALTH AND DISEASE
Michael J. Berridge
PHYSIOLOGICAL REVIEWS (2016)
Striatal cholinergic interneurons generate beta and gamma oscillations in the corticostriatal circuit and produce motor deficits
Krishnakanth Kondabolu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Positive modulators of the α7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's disease
Valentina Echeverria et al.
PROGRESS IN NEUROBIOLOGY (2016)
Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease
James A. G. Crispo et al.
PLOS ONE (2016)
Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions
Kalynda K. Gonzales et al.
ADDICTION REVIEWS 2015 (2015)
Modeling Parkinson's Disease Falls Associated With Brainstem Cholinergic Systems Decline
Aaron Kucinski et al.
BEHAVIORAL NEUROSCIENCE (2015)
Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease
Maryka Quik et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Transduced PEP-1-PON1 proteins regulate microglial activation and dopaminergic neuronal death in a Parkinson's disease model
Mi Jin Kim et al.
BIOMATERIALS (2015)
Role of alpha 7 nicotinic receptor in the immune system and intracelluliar signaling pathways
Robert Zdanowski et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions
Tanuja Bordia et al.
EXPERIMENTAL NEUROLOGY (2015)
Flies with Parkinson's disease
Roeland Vanhauwaert et al.
EXPERIMENTAL NEUROLOGY (2015)
Regulation of neuronal communication by G protein-coupled receptors
Yunhong Huang et al.
FEBS LETTERS (2015)
Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson's disease
D. Tripathy et al.
FREE RADICAL RESEARCH (2015)
Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females
Anne Almey et al.
HORMONES AND BEHAVIOR (2015)
The Nicotine Metabolite, Cotinine, Alters the Assembly and Trafficking of a Subset of Nicotinic Acetylcholine Receptors
Ashley M. Fox et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3 signaling pathway
Juan Deng et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Striatal cholinergic interneurons and cortico-striatal synaptic plasticity in health and disease
Marc Deffains et al.
MOVEMENT DISORDERS (2015)
The nicotinic cholinergic system function in the human brain
Frauke Nees
NEUROPHARMACOLOGY (2015)
Caregiver report of apathy predicts dementia in Parkinson's disease
Whitney Fitts et al.
PARKINSONISM & RELATED DISORDERS (2015)
Nicotinic ACh receptors as therapeutic targets in CNS disorders
Kelly T. Dineley et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Striatal Cholinergic Interneurons Control Motor Behavior and Basal Ganglia Function in Experimental Parkinsonism
Nicolas Maurice et al.
CELL REPORTS (2015)
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease
George E. Barreto et al.
FRONTIERS IN AGING NEUROSCIENCE (2015)
Dopaminergic Regulation of Striatal Interneurons in Reward and Addiction: Focus on Alcohol
Rhona Clarke et al.
NEURAL PLASTICITY (2015)
A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model
Ji Ae Lee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease
Marianna Amboni et al.
JOURNAL OF NEUROLOGY (2015)
New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine
J. Alex Grizzell et al.
NEUROCHEMICAL RESEARCH (2015)
Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
Walter J. Schulz-Schaeffer
BIOMOLECULES (2015)
R-(+) and S-(-) Isomers of Cotinine Augment Cholinergic Responses In Vitro and In Vivo
Alvin V. Terry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Psychiatric aspects of Parkinson's disease
Sandeep Grover et al.
JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE (2015)
Cotinine reduces depressive-like behavior, working memory deficits, and synaptic loss associated with chronic stress in mice
J. Alex Grizzell et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease
Jie Gao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?
Ada M. Tata et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Lithium stimulates human bone marrow derived mesenchymal stem cell proliferation through GSK-3β-dependent β-catenin/Wnt pathway activation
Zhenzhong Zhu et al.
FEBS JOURNAL (2014)
α7 nicotinic acetylcholine receptors control cytochrome c release from isolated mitochondria through kinase-mediated pathways
Galyna Gergalova et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Mitochondria express several nicotinic acetylcholine receptor subtypes to control various pathways of apoptosis induction
Olena Lykhmus et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Intracellular localization of the M1 muscarinic acetylcholine receptor through clathrin-dependent constitutive internalization is mediated by a C-terminal tryptophan-based motif
Junsuke Uwada et al.
JOURNAL OF CELL SCIENCE (2014)
A Major External Source of Cholinergic Innervation of the Striatum and Nucleus Accumbens Originates in the Brainstem
Daniel Dautan et al.
JOURNAL OF NEUROSCIENCE (2014)
Downregulation of the Wnt/β-catenin signaling pathway is involved in manganese-induced neurotoxicity in rat striatum and PC12 cells
Junkang Jiang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons
Xi Lu et al.
MOLECULAR NEURODEGENERATION (2014)
Muscarinic acetylcholine receptors: novel opportunities for drug development
Andrew C. Kruse et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
PRIMARY CULTURES OF RAT CORTICAL MICROGLIA TREATED WITH NICOTINE INCREASES IN THE EXPRESSION OF EXCITATORY AMINO ACID TRANSPORTER 1 (GLAST) VIA THE ACTIVATION OF THE α7 NICOTINIC ACETYLCHOLINE RECEPTOR
N. Morioka et al.
NEUROSCIENCE (2014)
Wnt/β-Catenin Signaling Is Required to Rescue Midbrain Dopaminergic Progenitors and Promote Neurorepair in Ageing Mouse Model of Parkinson's Disease
Francesca L'Episcopo et al.
STEM CELLS (2014)
M1 muscarinic acetylcholine receptor in Alzheimer's disease
Shangtong Jiang et al.
NEUROSCIENCE BULLETIN (2014)
Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 mice
Sagar Patel et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions
Alessandra Bonito-Oliva et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2014)
Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: Studies with parkinsonian nicotinic receptor knockout mice
Maryka Quik et al.
BIOCHEMICAL PHARMACOLOGY (2013)
α-Synuclein: The Long Distance Runner
Sonia George et al.
BRAIN PATHOLOGY (2013)
Effect of Nicotine on the Pharmacokinetics of Levodopa
Win Thiri Kyaw et al.
CLINICAL NEUROPHARMACOLOGY (2013)
Midbrain dopaminergic neurons: A review of the molecular circuitry that regulates their development
Shane V. Hegarty et al.
DEVELOPMENTAL BIOLOGY (2013)
Axon degeneration in Parkinson's disease
Robert E. Burke et al.
EXPERIMENTAL NEUROLOGY (2013)
Nicotine-encapsulated poly(lactic-co-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism
Manindra Nath Tiwari et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Parkinson disease: from pathology to molecular disease mechanisms
David T. Dexter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Cotinine and Blood Pressure Levels: Variability Omitted Once Again
Costas Thomopoulos et al.
HYPERTENSION (2013)
α-Synuclein Oligomers Impair Neuronal Microtubule-Kinesin Interplay
Iryna Prots et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mood disturbances and cognitive functioning in Parkinson's disease: The effects of disease duration and side of onset of motor symptoms
Paul S. Foster et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2013)
Novel contribution of cell surface and intracellular M1-muscarinic acetylcholine receptors to synaptic plasticity in hippocampus
Abu Syed Md Anisuzzaman et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Direct and GABA-mediated indirect effects of nicotinic ACh receptor agonists on striatal neurones
Ruixi Luo et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Functional roles of neurotransmitters and neuromodulators in the dorsal striatum
Jeehaeh Do et al.
LEARNING & MEMORY (2013)
Comparison of subcellular distribution and functions between exogenous and endogenous M1 muscarinic acetylcholine receptors
Shigeru Morishima et al.
LIFE SCIENCES (2013)
Nicotine Reduces Established Levodopa-induced Dyskinesias in a Monkey Model of Parkinson's Disease
Maryka Quik et al.
MOVEMENT DISORDERS (2013)
Neuroactive effects of cotinine on the hippocampus: Behavioral and biochemical parameters
R. B. de Aguiar et al.
NEUROPHARMACOLOGY (2013)
Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β1-42
Helena Janickova et al.
NEUROPHARMACOLOGY (2013)
Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: Gene and smoking status interaction
Lior Greenbaum et al.
PARKINSONISM & RELATED DISORDERS (2013)
Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Sudhakar Raja Subramaniam et al.
PROGRESS IN NEUROBIOLOGY (2013)
Nicotinic Receptor Agonists Reduce L-DOPA-Induced Dyskinesias in a Monkey Model of Parkinson's Disease
Danhui Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats
Alvin V. Terry et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Involvement of store-operated calcium signaling in EGF-mediated COX-2 gene activation in cancer cells
Jaw-Yuan Wang et al.
CELLULAR SIGNALLING (2012)
The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders I: Parkinsons Disease
Helineide Cristina Campos et al.
CNS & Neurological Disorders-Drug Targets (2012)
Cotinine: A Potential New Therapeutic Agent against Alzheimer's disease
Valentina Echeverria et al.
CNS NEUROSCIENCE & THERAPEUTICS (2012)
α7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson's Disease
Jun Kawamata et al.
CURRENT DRUG TARGETS (2012)
α7 Nicotinic Acetylcholine Receptor Subunit in Angiogenesis and Epithelial to Mesenchymal Transition
Smitha Pillai et al.
CURRENT DRUG TARGETS (2012)
Stress, depression and Parkinson's disease
Ann M. Hemmerle et al.
EXPERIMENTAL NEUROLOGY (2012)
Basal ganglia output to the PPN, a commentary
John F. Stein et al.
EXPERIMENTAL NEUROLOGY (2012)
a-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases
Zane S. Martin et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Role of Serotonergic 1A Receptor Dysfunction in Depression Associated with Parkinson's Disease
Benedicte Ballanger et al.
MOVEMENT DISORDERS (2012)
GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons
Daniel F. English et al.
NATURE NEUROSCIENCE (2012)
Mitochondrial CB1 receptors regulate neuronal energy metabolism
Giovanni Benard et al.
NATURE NEUROSCIENCE (2012)
Neurochemistry and the non-motor aspects of PD
I. Ferrer et al.
NEUROBIOLOGY OF DISEASE (2012)
Increased Oxidative Damage and Decreased Antioxidant Function in Aging Human Substantia Nigra Compared to Striatum: Implications for Parkinson's Disease
C. Venkateshappa et al.
NEUROCHEMICAL RESEARCH (2012)
A Feud that Wasn't: Acetylcholine Evokes Dopamine Release in the Striatum
D. James Surmeier et al.
NEURON (2012)
Striatal Dopamine Release Is Triggered by Synchronized Activity in Cholinergic Interneurons
Sarah Threlfell et al.
NEURON (2012)
Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
Marina R. Picciotto et al.
NEURON (2012)
Role for α6 nicotinic receptors in L-dopa-induced dyskinesias in parkinsonian mice
Maryka Quik et al.
NEUROPHARMACOLOGY (2012)
Cellular and molecular mechanisms of antioxidants in Parkinson's disease
Jhon Jairo Sutachan et al.
NUTRITIONAL NEUROSCIENCE (2012)
Cholinergic modulation of food and drug satiety and withdrawal
Nicole M. Avena et al.
PHYSIOLOGY & BEHAVIOR (2012)
Non-Motor Symptoms in Patients with Parkinson's Disease - Correlations with Inflammatory Cytokines in Serum
Daniel Lindqvist et al.
PLOS ONE (2012)
Mitochondrial Biology and Parkinson's Disease
Celine Perier et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Cotinine: beyond that expected, more than a biomarker of tobacco consumption
Valentina Echeverria Moran
FRONTIERS IN PHARMACOLOGY (2012)
Modulation of Striatal Projection Systems by Dopamine
Charles R. Gerfen et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)
Single-Cell Redox Imaging Demonstrates a Distinctive Response of Dopaminergic Neurons to Oxidative Insults
Maxx P. Horowitz et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
The cholinergic system and neostriatal memory functions
Robbert Havekes et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
The cerebrovascular role of the cholinergic neural system in Alzheimer's disease
Arenda H. E. A. Van Beek et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Involvement of the cholinergic system in conditioning and perceptual memory
Lianne Robinson et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
The cholinergic system and Parkinson disease
Nicolaas I. Bohnen et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Naturally-expressed nicotinic acetylcholine receptor subtypes
Jie Wu et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Modulation of Tau Phosphorylation by the Kinase PKR: Implications in Alzheimer's Disease
Anindita Bose et al.
BRAIN PATHOLOGY (2011)
Targeting Nicotinic Receptors for Parkinson's Disease Therapy
Maryka Quik et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2011)
Monoamine Oxidase B Inhibitors for the Treatment of Parkinson's Disease A Review of Symptomatic and Potential Disease-Modifying Effects
Anthony H. V. Schapira
CNS DRUGS (2011)
Cholinergic modulation of synaptic integration and dendritic excitability in the striatum
Ian Anton Oldenburg et al.
CURRENT OPINION IN NEUROBIOLOGY (2011)
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Karin Wirdefeldt et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2011)
Differential effects of subtype-specific nicotinic acetylcholine receptor agonists on early and late hippocampal LTP
Katja S. Kroker et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+
Damien Toulorge et al.
FASEB JOURNAL (2011)
Cotinine Reduces Amyloid-beta Aggregation and Improves Memory in Alzheimer's Disease Mice
Valentina Echeverria et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Stimulating Nicotinic Receptors Trigger Multiple Pathways Attenuating Cytotoxicity in Models of Alzheimer's and Parkinson's Diseases
Jun Kawamata et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Dopamine D1-histamine H3 Receptor Heteromers Provide a Selective Link to MAPK Signaling in GABAergic Neurons of the Direct Striatal Pathway
Estefana Moreno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Serotonin innervation of basal ganglia in monkeys and humans
Martin Parent et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2011)
Nicotine up-regulates alpha 4 beta 2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning
Rahul Srinivasan et al.
JOURNAL OF GENERAL PHYSIOLOGY (2011)
Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease
Isidre Ferrer et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D2/A2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease
Alessandro Tozzi et al.
JOURNAL OF NEUROSCIENCE (2011)
Nicotine Reduces L-DOPA-Induced Dyskinesias by Acting at β2*Nicotinic Receptors
Luping Z. Huang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Environmental tobacco smoke and Parkinson's disease
Susan Searles Nielsen et al.
MOVEMENT DISORDERS (2011)
Etiology and Pathogenesis of Parkinson's Disease
Anthony H. Schapira et al.
MOVEMENT DISORDERS (2011)
Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease
Marisa Srivareerat et al.
NEUROBIOLOGY OF AGING (2011)
Ethanol-induced modulation of synaptic output from the dorsolateral striatum in rat is regulated by cholinergic interneurons
Louise Adermark et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats
Luping Z. Huang et al.
NEUROPHARMACOLOGY (2011)
Muscarinic Receptor Occupancy and Cognitive Impairment: A PET Study with [11C](+)3-MPB and Scopolamine in Conscious Monkeys
Shigeyuki Yamamoto et al.
NEUROPSYCHOPHARMACOLOGY (2011)
SPONTANEOUS FIRING AND EVOKED PAUSES IN THE TONICALLY ACTIVE CHOLINERGIC INTERNEURONS OF THE STRIATUM
J. A. Goldberg et al.
NEUROSCIENCE (2011)
Serotonergic action on dorsal striatal function
Brian N. Mathur et al.
PARKINSONISM & RELATED DISORDERS (2011)
α6β2*and α4β2*Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease
Maryka Quik et al.
PHARMACOLOGICAL REVIEWS (2011)
Striatal origin of the pathologic beta oscillations in Parkinson's disease
M. M. McCarthy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: An overview of preclinical and clinical findings
Susanne Graef et al.
PSYCHOPHARMACOLOGY (2011)
Targeting neuronal populations of the striatum
Pierre F. Durieux et al.
FRONTIERS IN NEUROANATOMY (2011)
Centrality of striatal cholinergic transmission in basal ganglia function
Paola Bonsi et al.
FRONTIERS IN NEUROANATOMY (2011)
Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models
Jun Kawamata et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2011)
Mitochondrial Dysfunction in Parkinson's Disease
P. C. Keane et al.
PARKINSONS DISEASE (2011)
Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons
Sarah Threlfell et al.
FRONTIERS IN SYSTEMS NEUROSCIENCE (2011)
Active and passive smoking and risk of Parkinson's disease
K. Tanaka et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia
Walter J. Schulz-Schaeffer
ACTA NEUROPATHOLOGICA (2010)
Adenosine-cannabinoid receptor interactions. Implications for striatal function
Sergi Ferre et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Acetylcholine-Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
Deranda B. Lester et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
Depression Impairs Learning Whereas Anticholinergics Impair Transfer Generalization in Parkinson Patients Tested on Dopaminergic Medications
Mohammad M. Herzallah et al.
COGNITIVE AND BEHAVIORAL NEUROLOGY (2010)
Acetylcholine-dopamine balance hypothesis in the striatum: An update
Toshihiko Aosaki et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2010)
Kinetics of PIP2 metabolism and KCNQ2/3 channel regulation studied with a voltage-sensitive phosphatase in living cells
Bjoern H. Falkenburger et al.
JOURNAL OF GENERAL PHYSIOLOGY (2010)
Striatal Muscarinic Receptors Promote Activity Dependence of Dopamine Transmission via Distinct Receptor Subtypes on Cholinergic Interneurons in Ventral versus Dorsal Striatum
Sarah Threlfell et al.
JOURNAL OF NEUROSCIENCE (2010)
Nicotinic Receptor-Mediated Reduction in L-DOPA-Induced Dyskinesias May Occur via Desensitization
Tanuja Bordia et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Midbrain SERT in Degenerative Parkinsonisms: A 123I-FP-CIT SPECT Study
Francesco Roselli et al.
MOVEMENT DISORDERS (2010)
Smoking duration, intensity, and risk of Parkinson disease
H. Chen et al.
NEUROLOGY (2010)
PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
Bin Zheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Modulation of the activity of dopaminergic neurons by SK channels: a potential target for the treatment of Parkinson's disease?
Xiao-Kun Liu et al.
NEUROSCIENCE BULLETIN (2010)
Nicotine is a Selective Pharmacological Chaperone of Acetylcholine Receptor Number and Stoichiometry. Implications for Drug Discovery
Henry A. Lester et al.
AAPS JOURNAL (2009)
Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders
Thomas G. Beach et al.
ACTA NEUROPATHOLOGICA (2009)
Nicotinic acetylcholine receptors and the ascending dopamine pathways
Phil D. Livingstone et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Multiple roles for nicotine in Parkinson's disease
Maryka Quik et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Structural and functional diversity of native brain neuronal nicotinic receptors
Cecilia Gotti et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Smoking and Parkinson's disease: Does nicotine affect α-synuclein fibrillation?
Dong-Pyo Hong et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation
Rodrigo R. Resende et al.
CELL COMMUNICATION AND SIGNALING (2009)
Intracellular Metabotropic Glutamate Receptor 5 (mGluR5) Activates Signaling Cascades Distinct from Cell Surface Counterparts
Yuh-Jiin I. Jong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys
Luping Z. Huang et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Contrasting Effects of Allosteric and Orthosteric Agonists on M-1 Muscarinic Acetylcholine Receptor Internalization and Down-regulation
Rachel L. Thomas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Does smoking reduce the risk of Parkinson's disease through stimulation of the ubiquitin-proteasome system?
Mary Ann Chapman
MEDICAL HYPOTHESES (2009)
History of falls in Parkinson disease is associated with reduced cholinergic activity
N. I. Bohnen et al.
NEUROLOGY (2009)
Diversity of vertebrate nicotinic acetylcholine receptors
Neil S. Millar et al.
NEUROPHARMACOLOGY (2009)
Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
Edson X. Albuquerque et al.
PHYSIOLOGICAL REVIEWS (2009)
Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's disease
Selma Aybek et al.
PARKINSONISM & RELATED DISORDERS (2009)
Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer's Disease and Amyloid Neuroprotection
S. D. Buckingham et al.
PHARMACOLOGICAL REVIEWS (2009)
Enduring involvement of tau, β-amyloid, α-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC)
Judith Miklossy et al.
ACTA NEUROPATHOLOGICA (2008)
Cotinine-induced convergence of the cholinergic and PI3 kinase-dependent anti-inflammatory pathways in innate immune cells
Kunal Rehani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1
C. J. Langmead et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Mitochondrial import and accumulation of α-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain
Latha Devi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Striatal β-amyloid deposition in Parkinson disease with dementia
Michail E. Kalaitzakis et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease
Stefano Taverna et al.
JOURNAL OF NEUROSCIENCE (2008)
Cotinine selectively activates a Subpopulation of α3/α6β2*nicotinic receptors in monkey striatum
Kathryn O'Leary et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's disease
Tanuja Bordia et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
G protein-coupled receptors in and on the cell nucleus: A new signaling paradigm?
Benoit Boivin et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2008)
Chronic nicotine exposure induces a long-lasting and pathway-specific facilitation of LTP in the amygdala
Yan-You Huang et al.
LEARNING & MEMORY (2008)
Transcriptional regulation of mesencephalic dopaminergic neurons: The full circle of life and death
Kambiz N. Alavian et al.
MOVEMENT DISORDERS (2008)
Striatal Plasticity and Basal Ganglia Circuit Function
Anatol C. Kreitzer et al.
NEURON (2008)
From symphony to cacophony: Pathophysiology of the human basal ganglia in Parkinson disease
John T. Gale et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2008)
Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells
Karen Riveles et al.
NEUROTOXICOLOGY (2008)
Muscarinic acetylcholine receptors as CNS drug targets
Christopher J. Langmead et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Reduced striatal tyrosine hydroxylase in incidental Lewy body disease
Thomas Gerald Beach et al.
ACTA NEUROPATHOLOGICA (2008)
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
W. J. de Jonge et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Nicotinic receptors as CNS targets for Parkinson's disease
Maryka Quik et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Parkinson's disease
Bobby Thomas et al.
HUMAN MOLECULAR GENETICS (2007)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action
Hyun Jung Park et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders
Dariusz Pogocki et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Dopamine neuron systems in the brain:: an update
Anders Bjorklund et al.
TRENDS IN NEUROSCIENCES (2007)
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
David Sulzer
TRENDS IN NEUROSCIENCES (2007)
Cholinergic interneurons control the excitatory input to the striatum
Pavel Pakhotin et al.
JOURNAL OF NEUROSCIENCE (2007)
Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms
G. Mudo et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Basal ganglia macrocircuits
J. M. Tepper et al.
GABA AND THE BASAL GANGLIA: FROM MOLECULES TO SYSTEMS (2007)
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Juergen Wess et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Nicotinic acetylcholine receptors on basophils and mast cells
P. S. Sudheer et al.
ANAESTHESIA (2006)
Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates
Maryka Quik et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Striatal α6* nicotinic acetylcholine receptors:: Potential targets for Parkinson's disease therapy
M Quik et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
α7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal UP induction in β-amyloid infused rats
L Chen et al.
NEUROPHARMACOLOGY (2006)
Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival
J Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection
CY Chung et al.
HUMAN MOLECULAR GENETICS (2005)
Cognitive status correlates with neuropathologic stage in Parkinson disease
H Braak et al.
NEUROLOGY (2005)
Smoking, nicotine and Parkinson's disease
M Quik
TRENDS IN NEUROSCIENCES (2004)
Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons
GM Leinninger et al.
FASEB JOURNAL (2004)
Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling
T Züchner et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with lewy bodies, Parkinson's disease, and vascular dementia: In vitro binding study using 5-[I-125]-A-85380
SL Pimlott et al.
NEUROPSYCHOPHARMACOLOGY (2004)
M1 muscarinic receptor activation protects neurons from β-amyloid toxicity.: A role for Wnt signaling pathway
GG Farías et al.
NEUROBIOLOGY OF DISEASE (2004)
Nicotinic acetylcholine receptors and the regulation of neuronal signalling
F Dajas-Bailador et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives for MAPK-dependent amyloid precursor protein processing
M Yogev-Falach et al.
FASEB JOURNAL (2003)
Functional nicotinic acetylcholine receptors are expressed in B lymphocyte-derived cell lines
MV Skok et al.
MOLECULAR PHARMACOLOGY (2003)
Cotinine inhibits catecholamine release evoked by cholinergic stimulation from the rat adrenal medulla
YY Koh et al.
ARCHIVES OF PHARMACAL RESEARCH (2003)
Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: A potential, new model of Parkinson's disease
PM Carvey et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
Assembly and subunit diversity of nicotinic acetylcholine receptors
NS Millar
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
The potential role of cotinine in the cognitive and neuroprotective actions of nicotine
JJ Buccafusco et al.
LIFE SCIENCES (2003)
Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study
D Aarsland et al.
ARCHIVES OF NEUROLOGY (2003)
Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems
FM Zhou et al.
NEUROSCIENTIST (2003)
Cognitive impairments in advanced PD without dementia
J Green et al.
NEUROLOGY (2002)
Nicotine and nicotinic receptors; Relevance to Parkinson's disease
M Quik et al.
NEUROTOXICOLOGY (2002)
The genetic basis of Parkinson's disease
T Foltynie et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Non-steroidal anti-inflammatory drugs stimulate secretion of non-amyloidogenic precursor protein
Y Avramovich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity:: relevance for Parkinson's disease
R Soto-Otero et al.
BIOCHEMICAL PHARMACOLOGY (2002)
The heterogeneity of idiopathic Parkinson's disease
T Foltynie et al.
JOURNAL OF NEUROLOGY (2002)
Direct evidence that release-stimulating alpha 7*nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals
M Marchi et al.
JOURNAL OF NEUROCHEMISTRY (2002)
α7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block a β-amyloid-induced neurotoxicity
T Kihara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice
K Parain et al.
BRAIN RESEARCH (2001)
Intrinsic membrane properties underlying spontaneous tonic firing in neostriatal cholinergic interneurons
BD Bennett et al.
JOURNAL OF NEUROSCIENCE (2000)
α-Bungarotoxin-sensitive nicotinic receptors indirectly modulate [3H]dopamine release in rat striatal slices via glutamate release
S Kaiser et al.
MOLECULAR PHARMACOLOGY (2000)
Synaptic organisation of the basal ganglia
JP Bolam et al.
JOURNAL OF ANATOMY (2000)
Nicotinic receptors in the brain: Links between molecular biology and behavior
MR Picciotto et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Nicotine binding in human striatum: Elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication
JA Court et al.
NEUROSCIENCE (2000)
Share Paper
